Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
double-stranded RNA-clNPs
- Development stage
- Preclinical
- Lead developer
- Wilfrid Laurier University
- Modality
- RNA Therapeutics → Nucleic Acid Therapeutics, Nanoparticles → Drug Delivery Systems
- Administration
- Intramuscular, Intradermal, Intranasal
01
Overview
Double-stranded RNA-clNPs (dsRNA-clNPs) are an experimental immunotherapeutic formulation consisting of long double-stranded RNA (dsRNA) complexed with cationic polystyrene latex nanostructures (clNPs). The clNPs serve as a delivery vehicle to enhance the cellular uptake and stability of the dsRNA, which is otherwise susceptible to degradation. Once internalized by target cells, such as ovarian cancer cells, the dsRNA acts as a potent agonist for innate immune sensors including Toll-like receptor 3 (TLR3), RIG-I, and MDA5. This activation triggers a robust type I interferon response and the expression of interferon-stimulated genes (ISGs), effectively inducing an antiviral-like state that can potentiate the body's immune response against tumors. Research indicates that the clNP delivery system significantly improves the immunostimulatory capacity of dsRNA compared to uncomplexed nucleic acids.
- Other names
- cationic polystyrene latex nanostructures complexed with double-stranded RNAdsRNA-clNPs
02
Targets
EIF2AK2 (Interferon-induced protein kinase R)RLR (RIG-I-like receptors)TLR3 (Toll-like receptor 3)
Beyond the preview
Go deeper on double-stranded RNA-clNPs.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on double-stranded RNA-clNPs.